RxDoctor Payments Data

Amy Thorsen, MD

Colon & Rectal Surgery · Minneapolis, MNNPI 1215945944

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,782 of the $2,523 with a category attached, or 70.6%. 5 manufacturers reported payments, led by Intuitive Surgical at 46.1% of the total. 2024 is the largest year on record at $1,820, more than ten times the $32 reported in 2020.

$2,523in general payments, 2019–2025

Across 32 payments — averaging $78.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Medtronic$1K
  • Cook Biotech Incorporated$136
  • RTI Surgical, Inc$126
  • Johnson & Johnson$17
$29,104in research payments, 2019–2025

Across 1,000 payments — averaging $29.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$29K

What the payments were for

  • Travel & lodging$55322%
  • Food & beverage$1,78271%
  • Education$1807%
  • Gifts$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical8$1,163
Medtronic(2 entities)21$1,080
Cook Biotech Incorporated1$136
RTI Surgical, Inc1$126
Johnson & Johnson1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,523 in reported general payments places this provider in the 60th percentile of 64 colon & rectal surgery providers in Minnesota.

See all colon & rectal surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$56,809
Medicare patients
149
Services billed
271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl58$1,638
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl20$554
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl17$424
Neomycin Sulfate37$195
Metronidazole42$114
Oxycodone Hcl22$58
Ondansetron Hcl34$47

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →